These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27609180)

  • 1. IL-1β induces IL-6 production and increases invasiveness and estrogen-independent growth in a TG2-dependent manner in human breast cancer cells.
    Oh K; Lee OY; Park Y; Seo MW; Lee DS
    BMC Cancer; 2016 Sep; 16(1):724. PubMed ID: 27609180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells.
    Oh K; Ko E; Kim HS; Park AK; Moon HG; Noh DY; Lee DS
    Breast Cancer Res; 2011 Oct; 13(5):R96. PubMed ID: 21967801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer.
    Mehta K; Fok J; Miller FR; Koul D; Sahin AA
    Clin Cancer Res; 2004 Dec; 10(23):8068-76. PubMed ID: 15585642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways.
    Kumar S; Donti TR; Agnihotri N; Mehta K
    Int J Cancer; 2014 Jun; 134(12):2798-807. PubMed ID: 24477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
    Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
    Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 2 is involved in amyloid-beta
    Currò M; Gangemi C; Giunta ML; Ferlazzo N; Navarra M; Ientile R; Caccamo D
    Amino Acids; 2017 Mar; 49(3):659-669. PubMed ID: 27864692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype.
    Brown KD
    Breast Cancer Res Treat; 2013 Jan; 137(2):329-36. PubMed ID: 23224146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
    Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
    Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
    Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
    Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
    Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
    Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
    Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase-2: evolution from pedestrian protein to a promising therapeutic target.
    Agnihotri N; Mehta K
    Amino Acids; 2017 Mar; 49(3):425-439. PubMed ID: 27562794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
    Attarwala H; Clausen V; Chaturvedi P; Amiji MM
    Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer.
    Agnihotri N; Kumar S; Mehta K
    Breast Cancer Res; 2013 Feb; 15(1):202. PubMed ID: 23673317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells.
    Kumar A; Gao H; Xu J; Reuben J; Yu D; Mehta K
    PLoS One; 2011; 6(6):e20701. PubMed ID: 21687668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of phospho mutant forms of transglutaminase 2 downregulates epidermal growth factor receptor.
    Wang Y; Ande SR; Mishra S
    Biochem Biophys Res Commun; 2012 Jan; 417(1):251-5. PubMed ID: 22142843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
    Mangala LS; Fok JY; Zorrilla-Calancha IR; Verma A; Mehta K
    Oncogene; 2007 Apr; 26(17):2459-70. PubMed ID: 17043648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.